Pardis Momeni, Kristofer Årestedt, Anette Alvariza, Elisabeth Winnberg, Ida Goliath, Åsa Kneck, Janeth Leksell, Mats Ewertzon (2022). A survey study of family members' encounters with healthcare services within the care of older people, psychiatric care, palliative care and diabetes care
Pardis Momeni, Mats Ewertzon, Kristofer Årestedt, Elisabeth Winnberg (2022). Family Members’ Experiences with the Healthcare Professionals in Nursing Homes: A Survey Study
Anna Klarare, Ing-Britt Rydeman, Åsa Kneck, Elisabeth Bos Sparén, Elisabeth Winnberg, Birgitta Bisholt (2022). Methods and strategies to promote academic literacies in health professions: A scoping review
Michaela Karlstedt, Ulrika Winnberg, Elisabeth Winnberg (2021). Sense of Coherence in partners to persons with Huntington's disease
Guillermo Goode-Romero, Ulrika Winnberg, Laura Domínguez, Ilich A Ibarra, Rubicelia Vargas, Elisabeth Winnberg, Ana Martínez (2020). New information of dopaminergic agents based on quantum chemistry calculations
Mats Ewertzon, Anette Alvariza, Elisabeth Winnberg, Janeth Leksell, Birgitta Andershed, Ida Goliath, Pardis Momeni, Åsa Kneck, Maria Skott, Kristofer Årestedt (2018). Adaptation and evaluation of the Family Involvement and Alienation Questionnaire for use in the care of older people, psychiatric care, palliative care and diabetes care
Elisabeth Winnberg, Ulrika Winnberg, Lilian Pohlkamp, Anette Hagberg (2018). What to Do with a Second Chance in Life?: Long-Term Experiences of Non-carriers of Huntington's Disease
Michaela Karlstedt, S. M. Fereshtehnejad, Elisabeth Winnberg, D. Aarsland, J. Lökk (2017). Psychometric properties of the mutuality scale in Swedish dyads with Parkinson's disease
Martin Paucar, Fengqing Xiang, Richard Moore, Ruth Walker, Elisabeth Winnberg, Per Svenningsson (2013). Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation.
Oliver W Quarrell, Olivia Handley, Kirsty O'Donovan, Christine Dumoulin, Maria Ramos-Arroyo, Ida Biunno, Peter Bauer, Margaret Kline, G Bernhard Landwehrmeyer (2012). Discrepancies in reporting the CAG repeat lengths for Huntington's disease.
Anette Hagberg, The-Hung Bui, Elisabeth Winnberg (2011). More appreciation of life or regretting the test? Experiences of living as a mutation carrier of Huntington's disease
Michael Orth, O J Handley, C Schwenke, S Dunnett, E J Wild, S J Tabrizi, G B Landwehrmeyer (2011). Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
K Marder, H Zhao, S Eberly, C M Tanner, D Oakes, I Shoulson (2009). Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.
Elisabeth Winnberg Almqvist, The Huntington Study Group PHAROS Investigators (2006). At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden (2004). A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
Luc Djoussé, Beth Knowlton, Michael R Hayden, Elisabeth W Almqvist, Ryan R Brinkman, Christopher A Ross, Russel L Margolis, Adam Rosenblatt, Alexandra Durr, Catherine Dode, Patrick J Morrison, Andrea Novelletto, Marina Frontali, Ronald J A Trent, Elizabeth McCusker, Estrella Gómez-Tortosa, David Mayo Cabrero, Randi Jones, Andrea Zanko, Martha Nance, Ruth K Abramson, Oksana Suchowersky, Jane S Paulsen, Madaline B Harrison, Qiong Yang, L Adrienne Cupples, Jayalakshmi Mysore, James F Gusella, Marcy E MacDonald, Richard H Myers (2004). Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
Russell L Margolis, Susan E Holmes, Adam Rosenblatt, Lisa Gourley, Elizabeth O'Hearn, Christopher A Ross, William K Seltzer, Ruth H Walker, Tetsuo Ashizawa, Astrid Rasmussen, Michael Hayden, Elisabeth W Almqvist, Juliette Harris, Stanley Fahn, Marcy E MacDonald, Jayalakshmi Mysore, Takayoshi Shimohata, Shoji Tsuji, Nicholas Potter, Kazuhiro Nakaso, Yoshiki Adachi, Kenji Nakashima, Thomas Bird, Amanda Krause, Penny Greenstein (2004). Huntington's Disease-like 2 (HDL2) in North America and Japan.
Jian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, Ryan R Brinkman, Alexandra Durr, Catherine Dodé, Patrick J Morrison, Oksana Suchowersky, Christopher A Ross, Russell L Margolis, Adam Rosenblatt, Estrella Gómez-Tortosa, David Mayo Cabrero, Andrea Novelletto, Marina Frontali, Martha Nance, Ronald J A Trent, Elizabeth McCusker, Randi Jones, Jane S Paulsen, Madeline Harrison, Andrea Zanko, Ruth K Abramson, Ana L Russ, Beth Knowlton, Luc Djoussé, Jayalakshmi S Mysore, Suzanne Tariot, Michael F Gusella, Vanessa C Wheeler, Larry D Atwood, L Adrienne Cupples, Marie Saint-Hilaire, Jang-Ho J Cha, Steven M Hersch, Walter J Koroshetz, James F Gusella, Marcy E MacDonald, Richard H Myers (2003). A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study.
E H Aylward, A Rosenblatt, K Field, V Yallapragada, K Kieburtz, M McDermott, L A Raymond, E W Almqvist, M Hayden, C A Ross (2003). Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study.
Elisabeth W. Almqvist (2003). Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study.
Ferdinando Squitieri, Cinzia Gellera, Milena Cannella, Caterina Mariotti, Giuliana Cislaghi, David C Rubinsztein, Elisabeth W Almqvist, David Turner, Anne-Catherine Bachoud-Lévi, Sheila A Simpson, Martin Delatycki, Vittorio Maglione, Michael R Hayden, Stefano Di Donato (2003). Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course.
L Djoussé, B Knowlton, M Hayden, E W Almqvist, R Brinkman, C Ross, R Margolis, A Rosenblatt, A Durr, C Dode, P J Morrison, A Novelletto, M Frontali, R J A Trent, E McCusker, E Gómez-Tortosa, D Mayo, R Jones, A Zanko, M Nance, R Abramson, O Suchowersky, J Paulsen, M Harrison, Q Yang, L A Cupples, J F Gusella, M E MacDonald, R H Myers (2003). Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.
S Creighton, E W Almqvist, D MacGregor, B Fernandez, H Hogg, J Beis, J P Welch, C Riddell, R Lokkesmoe, M Khalifa, J MacKenzie, A Sajoo, S Farrell, F Robert, A Shugar, A Summers, W Meschino, D Allingham-Hawkins, T Chiu, A Hunter, J Allanson, H Hare, J Schween, L Collins, S Sanders, C Greenberg, S Cardwell, E Lemire, P MacLeod, M R Hayden (2003). Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.
F Squitieri, E W Almqvist, M Cannella, G Cislaghi, M R Hayden (2003). Predictive testing for persons at risk for homozygosity for CAG expansion in the Huntington disease gene.
E W Almqvist, R R Brinkman, S Wiggins, M R Hayden (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease.
Elisabeth W. Almqvist (2001). A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease
A Rosenblatt, R R Brinkman, K Y Liang, E W Almqvist, R L Margolis, C Y Huang, M Sherr, M L Franz, M H Abbott, M R Hayden, C A Ross (2001). Familial influence on age of onset among siblings with Huntington disease.
E W Almqvist, D S Elterman, P M MacLeod, M R Hayden (2001). High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia.
D Falush, E W Almqvist, R R Brinkmann, Y Iwasa, M R Hayden (2001). Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases.
C J Otto, E Almqvist, M R Hayden, S E Andrew (2001). The "flap" endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion underlying Huntington disease.
D Tsuang, E W Almqvist, H Lipe, F Strgar, L DiGiacomo, D Hoff, C Eugenio, M R Hayden, T D Bird (2000). Familial aggregation of psychotic symptoms in Huntington's disease.
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden (1999). A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.
O Bruland, E W Almqvist, Y P Goldberg, H Boman, M R Hayden, P M Knappskog (1999). Accurate determination of the number of CAG repeats in the Huntington disease gene using a sequence-specific internal DNA standard.
B Kremer, C M Clark, E W Almqvist, L A Raymond, P Graf, C Jacova, M Mezei, M A Hardy, B Snow, W Martin, M R Hayden (1999). Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial.
F Xiang, E W Almqvist, M Huq, A Lundin, M R Hayden, L Edström, M Anvret, Z Zhang (1998). A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.
S S Chong, E Almqvist, H Telenius, L LaTray, K Nichol, B Bourdelat-Parks, Y P Goldberg, B R Haddad, F Richards, D Sillence, C R Greenberg, E Ives, G Van den Engh, M R Hughes, M R Hayden (1997). Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses.
G M Goellner, D Tester, S Thibodeau, E Almqvist, Y P Goldberg, M R Hayden, C T McMurray (1997). Different mechanisms underlie DNA instability in Huntington disease and colorectal cancer.
T B Wahlin, A Lundin, L Bäckman, E Almqvist, A Haegermark, B Winblad, M Anvret (1997). Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status.
E Almqvist, S Adam, M Bloch, A Fuller, P Welch, D Eisenberg, D Whelan, D Macgregor, W Meschino, M R Hayden (1997). Risk reversals in predictive testing for Huntington disease.
R R Brinkman, M M Mezei, J Theilmann, E Almqvist, M R Hayden (1997). The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.
D C Rubinsztein, J Leggo, R Coles, E Almqvist, V Biancalana, J J Cassiman, K Chotai, M Connarty, D Crauford, A Curtis, D Curtis, M J Davidson, A M Differ, C Dode, A Dodge, M Frontali, N G Ranen, O C Stine, M Sherr, M H Abbott, M L Franz, C A Graham, P S Harper, J C Hedreen, M R Hayden (1996). Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.
E Almqvist, N Spence, K Nichol, S E Andrew, J Vesa, L Peltonen, M Anvret, J Goto, I Kanazawa, Y P Goldberg (1995). Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.
Y P Goldberg, C T McMurray, J Zeisler, E Almqvist, D Sillence, F Richards, A M Gacy, J Buchanan, H Telenius, M R Hayden (1995). Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population.
B Kremer, E Almqvist, J Theilmann, N Spence, H Telenius, Y P Goldberg, M R Hayden (1995). Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes.
H Telenius, E Almqvist, B Kremer, N Spence, F Squitieri, K Nichol, U Grandell, E Starr, C Benjamin, I Castaldo (1995). Somatic mosaicism in sperm is associated with intergenerational (CAG)n changes in Huntington disease.
I Alafuzoff, E Almqvist, R Adolfsson, S Lake, W Wallace, D A Greenberg, B Winblad (1994). A comparison of multiplex and simplex families with Alzheimer's disease/senile dementia of Alzheimer type within a well defined population.
B Kremer, P Goldberg, S E Andrew, J Theilmann, H Telenius, J Zeisler, F Squitieri, B Lin, A Bassett, E Almqvist (1994). A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
F Squitieri, S E Andrew, Y P Goldberg, B Kremer, N Spence, J Zeisler, K Nichol, J Theilmann, J Greenberg, J Goto, Elisabeth Almqvist (1994). DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence.
E Almqvist, S Andrew, J Theilmann, P Goldberg, J Zeisler, U Drugge, U Grandell, M Tapper-Persson, B Winblad, M Hayden (1994). Geographical distribution of haplotypes in Swedish families with Huntington's disease.
S E Andrew, Y P Goldberg, B Kremer, F Squitieri, J Theilmann, J Zeisler, H Telenius, S Adam, E Almquist, M Anvret (1994). Huntington disease without CAG expansion: phenocopies or errors in assignment?
S Andrew, J Theilmann, E Almqvist, A Norremolle, G Lucotte, M Anvret, S A Sorensen, J C Turpin, M R Hayden (1993). DNA analysis of distinct populations suggests multiple origins for the mutation causing Huntington disease.
L Lannfelt, M Viitanen, K Johansson, K Axelman, L Lilius, E Almqvist, B Winblad (1993). Low frequency of the APP 670/671 mutation in familial Alzheimer's disease in Sweden.
H Telenius, H P Kremer, J Theilmann, S E Andrew, E Almqvist, M Anvret, C Greenberg, J Greenberg, G Lucotte, F Squitieri (1993). Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.
E Almqvist, S Lake, K Axelman, K Johansson, B Winblad (1993). Screening of amyloid precursor protein gene mutation (APP 717 Val-->Ile) in Swedish families with Alzheimer's disease.
B Mattsson, E W Almqvist (1991). Attitudes towards predictive testing in Huntington's disease--a deep interview study in Sweden.
- Last updated:
- 27 December 2021